baca pustaka respi asni
TRANSCRIPT
-
8/2/2019 Baca Pustaka Respi Asni
1/26
Click to edit Master subtitle style
3/15/12
IMMUNE RECONSTITUTION
INFLAMMATORY SYNDROME (IRIS)TERKAIT INFEKSI TUBERCULOSIS (TB)DAN VAKSINASI BCG PADA ANAKDENGAN HIVASNI RAHAYU
Article Review
RespirologySubdivision
-
8/2/2019 Baca Pustaka Respi Asni
2/26
3/15/12
HIV-IRIS inchildren
limited data
115.000
Get ART
780.000 need ART
Child with HIV2,5 millions
INTRODUCTION
HIV ARTIRIS ??
76-90% dead infirst 6 mo ART
?
-
8/2/2019 Baca Pustaka Respi Asni
3/26
3/15/12
EPIDEMIOLOGY
-
8/2/2019 Baca Pustaka Respi Asni
4/26
3/15/12
IRIS DEFENITION
Case Definition: Consensus Criteria for Diagnosis of Pediatric IRIS
1. Evidence of clinical response to ART with:
a. Virologic response with >1 log10 copies/mL decrease in HIV RNA (ifpossible).1
2. Clinical deterioration from an infectious or inflammatory conditiontemporally related to the initiation of ARTa. Unmasking IRIS requires a new active diagnosis2b. For Paradoxical TB-IRIS, refer to Table 3 for clinical criteria
3. Symptoms cannot be explained by:a. An alternate infection or neoplasmb. Treatment failure of the opportunistic infection.3c. Adverse drug reactiond. Complete non-compliance to ART or TB treatment4
1
IRIS can occur in the absence of a meaningful rise in CD4 count. In ART nave persons, an initial virologic response generally alwaysoccurs. In nonnave persons or with known ART resistance, proof of virologic response becomes more important.2
Unmasking caveats: Active infections, such as TB, should be excluded at time of ART initiation. Diagnosis of incident TB infections should conform to national or WHO guidelines. In children, bacteriologic confirmation may not
always be achieved. Unmasked incident infections may have accelerated presentations with exaggerated symptoms. Refeeding syndrome of malnourished children may contribute to unmasking opportunistic infections . Generally occurs within 6 months after ART initiation.3
Paradoxical IRIS can occur with MDR and XDR TB; however, the primary concern is the efficacy of the TB therapy. For TB-IRIS, non
compliance and TB treatment failure are critical to exclude.4
Even with imperfect ART compliance and lack of HIV virologic suppression, immunologic reconstitution and CD4 rise can occur
-
8/2/2019 Baca Pustaka Respi Asni
5/26
3/15/12
Innateimmunedetection ofHIV PAMPs.
(pathogen-associatedmolecularpatterns)
Model of the HIV
life cycle andinteractionsbetween HIV andinnate immunity:-Detection ofHIV by any of
these threeinnate immunepathwaysactivates genesfor IFN-a.
Yan and Lieberman
2011
HIV RNA
CA=nascent capsid protein
Most striking early events are related to activation of the IFN-a and Interferon
-
8/2/2019 Baca Pustaka Respi Asni
6/26
3/15/12
IRISPathophysiology
CD4 response to HAART1st:Rapid redistribution of CD4 memorycells from peripheral lymphoid tissue
Then: More gradual restoration of nave
CD4 cells from thymus Dyregulated responseShift to Th1 pro-inflammatory cytokine
profile
Lack of immune regulation Inability to produce regulatory cytokines High burden of offending antigen
-
8/2/2019 Baca Pustaka Respi Asni
7/263/15/12
-
8/2/2019 Baca Pustaka Respi Asni
8/263/15/12
Common Scenarios of HIV Immune Reconstitution InflammatorySyndrome (IRIS)
Unmasking IRIS Occult, subclinical opportunistic infection Unmasked by immune recovery following ART initiation Infectious pathogen typically detectable
Paradoxical IRIS Clinical recrudescence of a successfully treated infection Symptomatic relapse despite initial clinical improvement andcontinued microbiologic treatment success. Antigen driven immune activation, often with a robust immune
response in the setting of few or no detectable organisms. Culture may be sterile due to effective opportunistic infectiontreatment
-
8/2/2019 Baca Pustaka Respi Asni
9/263/15/12
Paradoxical IRIS Exacerbation and/or
return of symptoms ofcurrently or recentlytreated OI
Non-viable antigens ofpathogens
Usually 3 months ofHAART
Months to years forimmune recovery
(CMV) uveitis Examples: TB,Cryptococcal disease,Kaposis sarcoma (KS)
Unmasking IRIS Clinical
presentation ofpreexisting,subclinical OIafter HAART
initiation Viable pathogens Usually 3
months of HAART
Example: Non-tuberculousmycobacteria(MAC), TB
-
8/2/2019 Baca Pustaka Respi Asni
10/263/15/12
-
8/2/2019 Baca Pustaka Respi Asni
11/263/15/12
-
8/2/2019 Baca Pustaka Respi Asni
12/263/15/12
-
8/2/2019 Baca Pustaka Respi Asni
13/263/15/12
HIV / TB COINFECTION
HIGH TB PREV.
TB IRIS INCIDEN 3,4 %
HIV PREV. 1-
70 %10 %
CHILDREN.
UNMASKING TB 6,2 %FROM INITIATE ART
UGANDA
SOUTH AFRICA
http://f/KOINFEKSI%20TB-HIV.pdfhttp://f/KOINFEKSI%20TB-HIV.pdf -
8/2/2019 Baca Pustaka Respi Asni
14/263/15/12
Infectious or Inflammatory Clinical Criteria for Paradoxical TB-IRIS
Clinical Criteria:At least 1 major clinical criterion or 2 minor clinical criteria are required:
Major criteria1. New or enlarging lymph nodes, fistulas, cold abscesses, or other focal
tissue involvement.2. New or worsening radiological features of TB3. New or worsening central nervous system TB (meningitis or focal
neurological deficit).4. New or worsening TB serositis (pleural effusion, ascites, or pericardial
effusion) or arthritis.5. Signs of tuberculin hypersensitivity (e.g. phlyctenular conjunctivitis,
erythema nodosum).Minor criteria1. New or worsening constitutional symptoms such as fever, night sweats
or weight loss.2. New or worsening respiratory symptoms such as cough, dyspnea, or
stridor.3. New or worsening abdominal pain, discomfort, and/or distension with or
without palpable mass including hepatosplenomegaly4. Resolution of clinical or radiological findings of the suspected IRIS
episode without change in ART, TB treatment, or additional antimicrobialtherapy
Supportive observations1. Conversion of TST negative to positive in patients receiving TB
treatment and ART at time of an IRIS event, or >5x increase frombaseline in interferon release assay (e.g. QuantiFERON, ELISPOT).
t
-
8/2/2019 Baca Pustaka Respi Asni
15/263/15/12
s actor or nchildren
Malnourished
Severe CD4 depletion Clinically WHO std III & IV
History of TB
-
8/2/2019 Baca Pustaka Respi Asni
16/263/15/12
-
8/2/2019 Baca Pustaka Respi Asni
17/263/15/12
Guidelines for ART Start in TB/HIVpatients
Guideline/Recommenda
tionCD4 count
strataInterval
SA national ART
programme
2004
CD4 35
2 wks 8 wks8 wks6 mo
DHHS (USA)
2008
CD4 350
2 wks
8 wks8 wks8 24 wks ordefer
British 2010 CD4
-
8/2/2019 Baca Pustaka Respi Asni
18/263/15/12
-
8/2/2019 Baca Pustaka Respi Asni
19/263/15/12
BCG-IRISWHO currently recommends administering
a single dose of BCG vaccine to all infantsliving in areas where tuberculosis is highlyendemic as well as to infants and childrenat particular risk of exposure to
tuberculosis in countries with lowendemicity.
BCG vaccine is contraindicated in people
with impaired immunity, and WHO does notrecommend BCG vaccination for childrenwith symptomatic HIV infection.
-
8/2/2019 Baca Pustaka Respi Asni
20/263/15/12
-
8/2/2019 Baca Pustaka Respi Asni
21/263/15/12
N l t ft BCG
-
8/2/2019 Baca Pustaka Respi Asni
22/263/15/12
Normal events after BCG G. HusseySATVI,UCT
BCG IRIS
-
8/2/2019 Baca Pustaka Respi Asni
23/263/15/12
BCG IRIS
Courtesy: MarkCotton
-
8/2/2019 Baca Pustaka Respi Asni
24/263/15/12
-
8/2/2019 Baca Pustaka Respi Asni
25/263/15/12
-
8/2/2019 Baca Pustaka Respi Asni
26/26
THANKYOU